Drug-induced hyperphagia: what can we learn from psychiatric medications?
- PMID: 18753398
- DOI: 10.1177/0148607108321708
Drug-induced hyperphagia: what can we learn from psychiatric medications?
Abstract
This brief review examines hyperphagia and associated weight gain as undesirable side effects of psychiatric medications; exploring the scope of the problem, proposed mechanisms, and potential interventions. Mechanisms of action appear to include drug-mediated effects on hypothalamic appetite pathways that have been implicated in other etiologies of obesity. There is great individual variation in response to these medications as well as variation in the degree of weight gain within drug classes. Gene polymorphisms may be a key factor in determining individual variations in response. Better understanding of the underlying mechanisms can guide useful interventions. Medication selection and dosing appear to be important strategies to minimize adverse weight gain.
Similar articles
-
Psychiatric medication-induced obesity: treatment options.Obes Rev. 2004 Nov;5(4):233-8. doi: 10.1111/j.1467-789X.2004.00149.x. Obes Rev. 2004. PMID: 15458397 Review.
-
Weight gain associated with use of psychotropic medications.J Clin Psychiatry. 1999;60 Suppl 21:16-9. J Clin Psychiatry. 1999. PMID: 10548137 Review.
-
Psychiatric medication-induced obesity: a review.Obes Rev. 2004 May;5(2):115-21. doi: 10.1111/j.1467-789X.2004.00139.x. Obes Rev. 2004. PMID: 15086865 Review.
-
Medications associated with weight gain.Ann Pharmacother. 2005 Dec;39(12):2046-55. doi: 10.1345/aph.1G333. Epub 2005 Nov 8. Ann Pharmacother. 2005. PMID: 16278256 Review.
-
Naltrexone does not prevent the weight gain and hyperphagia induced by the antipsychotic drug sulpiride in rats.Appetite. 2000 Feb;34(1):77-86. doi: 10.1006/appe.1999.0284. Appetite. 2000. PMID: 10744894
Cited by
-
Susceptibility of male wild type mouse strains to antipsychotic-induced weight gain.Physiol Behav. 2020 Jun 1;220:112859. doi: 10.1016/j.physbeh.2020.112859. Epub 2020 Mar 7. Physiol Behav. 2020. PMID: 32156556 Free PMC article.
-
Metabolomic profiles associated with a mouse model of antipsychotic-induced food intake and weight gain.Sci Rep. 2020 Oct 29;10(1):18581. doi: 10.1038/s41598-020-75624-2. Sci Rep. 2020. PMID: 33122657 Free PMC article.
-
Uncoupling overeating and fat storage by modulation of different serotonergic receptors.bioRxiv [Preprint]. 2025 Mar 19:2025.03.18.644037. doi: 10.1101/2025.03.18.644037. bioRxiv. 2025. PMID: 40166358 Free PMC article. Preprint.
-
A comparison of the nutrient intake of a community-dwelling first-episode psychosis cohort, aged 19-64 years, with data from the UK population.J Nutr Sci. 2015 Aug 20;4:e28. doi: 10.1017/jns.2015.18. eCollection 2015. J Nutr Sci. 2015. PMID: 26495120 Free PMC article.
-
Doxepin Exacerbates Renal Damage, Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Urinary Chromium Loss in Obese Mice.Pharmaceuticals (Basel). 2021 Mar 16;14(3):267. doi: 10.3390/ph14030267. Pharmaceuticals (Basel). 2021. PMID: 33809508 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical